NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TOKIWA-Bio Inc.

TOKIWA-Bio Inc.

Private
TsukubaHealthcare & Life Scienceshttps://tokiwa-bio.com/

Last Round

Series B

Oct 20, 2025

Total Funding Raised

$5.47M

Company Overview

TOKIWA-Bio Inc. is a biotechnology company that develops and commercializes its Stealth RNA Vector (SRV) technology for gene therapy, regenerative medicine, and biopharmaceutical manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

Stealth RNA VectorSRVgene deliveryRNA vectornon-viral vectorgene therapycell therapyiPSC reprogrammingnon-integrating vectorregenerative medicinecell reprogramminggene expression systemcustom vector productiondrug discovery servicesresearch reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TOKIWA-Bio Inc. Comps

Public and private peers based on sector, stage, and business model.

TOKIWA-Bio Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TOKIWA-Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 20, 2025
Series ANov 10, 2017

TOKIWA-Bio Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Monthly visitors grew 76% MoM, reaching 2.3K.

  • May 2, 2025

    Monthly visitors increased 281% MoM.

TOKIWA-Bio Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TOKIWA-Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TOKIWA-Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTsukuba
Employee Range1
Year Founded2014
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.